ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
This Quarter Return
+2.22%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$250M
AUM Growth
+$250M
(-51%)
Cap. Flow
-$238M
Cap. Flow
% of AUM
-95.17%
Top 10 Holdings %
Top 10 Hldgs %
82.54%
Holding
56
New
3
Increased
2
Reduced
13
Closed
17
Top Buys
| 1 |
KalVista Pharmaceuticals
KALV
|
$2.85M |
| 2 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$1.63M |
| 3 |
AMRN
Amarin Corp
AMRN
|
$1.16M |
| 4 |
Xenon Pharmaceuticals
XENE
|
$429K |
| 5 |
Coherus Oncology, Inc. Common Stock
CHRS
|
$140K |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$56.1M |
| 2 |
argenx
ARGX
|
$26.4M |
| 3 |
Iovance Biotherapeutics
IOVA
|
$20.3M |
| 4 |
Ascendis Pharma
ASND
|
$17M |
| 5 |
Veracyte
VCYT
|
$15M |
Sector Composition
| 1 | Healthcare | 81.68% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
1
DELISTED
Immunomedics Inc
IMMU
| $42.8M | 15.27% | 2,055,500 -2,694,500 | -57% | -$56.1M |
|
2
Assembly Biosciences
ASMB
$190M
| $34.5M | 12.32% | 930,000 -232,000 | -20% | -$8.62M |
|
|
3
Iovance Biotherapeutics
IOVA
$807M
| $25M | 8.92% | 2,222,701 -1,802,299 | -45% | -$20.3M |
|
|
KDMN
4
DELISTED
Kadmon Holdings, Inc.
KDMN
| $24.7M | 8.81% | 7,395,000 -1,665,014 | -18% | -$5.56M |
|
|
CEMI
5
DELISTED
Chembio diagnostics, Inc.
CEMI
| $21.3M | 7.61% | 2,030,533 | – | – |
|
6
Arrowhead Research
ARWR
$3.05B
| $14.9M | 5.3% | 775,000 -255,330 | -25% | -$4.89M |
|
7
IRIDEX
IRIX
$22.8M
| $12.4M | 4.41% | 1,947,500 -52,500 | -3% | -$333K |
|
|
CASM
8
DELISTED
CAS Medical Systems, Inc.
CASM
| $12M | 4.28% | 5,263,508 | – | – |
|
|
9
Veracyte
VCYT
$2.39B
| $10.4M | 3.72% | 1,092,500 -1,567,710 | -59% | -$15M |
|
|
10
argenx
ARGX
$43.6B
| $7.96M | 2.84% | 105,000 -348,233 | -77% | -$26.4M |
|
11
Madrigal Pharmaceuticals
MDGL
$9.76B
| $7.07M | 2.52% | 33,000 -1,803 | -5% | -$386K |
|
|
12
Xenon Pharmaceuticals
XENE
$2.98B
| $6.37M | 2.27% | 482,500 +32,500 | +7% | +$429K |
|
|
13
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $5.83M | 2.08% | 353,500 +8,500 | +2% | +$140K |
|
|
14
Ascendis Pharma
ASND
$11.8B
| $5.07M | 1.81% | 71,500 -239,611 | -77% | -$17M |
|
|
BHVN
15
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $4.98M | 1.77% | 132,500 -27,500 | -17% | -$1.03M |
|
|
ACER
16
DELISTED
Acer Therapeutics Inc. Common Stock (DE)
ACER
| $3.37M | 1.2% | 109,270 | – | – |
|
|
VRAY
17
DELISTED
ViewRay, Inc.
VRAY
| $2.92M | 1.04% | 311,500 -1,183,500 | -79% | -$11.1M |
|
|
18
KalVista Pharmaceuticals
KALV
$678M
| $2.85M | 1.02% | +128,844 | New | +$2.85M |
|
19
Dianthus Therapeutics
DNTH
$759M
| $2.04M | 0.73% | 170,000 | – | – |
|
|
ECYT
20
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $1.63M | 0.58% | +92,000 | New | +$1.63M |
|
|
AMRN
21
Amarin Corp
AMRN
$311M
| $1.16M | 0.41% | +71,000 | New | +$1.16M |
|
|
ALIM
22
DELISTED
Alimera Sciences, Inc.
ALIM
| $262K | 0.09% | 267,500 -706,818 | -73% | -$692K |
|
23
Outlook Therapeutics
OTLK
$37.8M
| $29K | 0.01% | 29,082 | – | – |
|
24
Apellis Pharmaceuticals
APLS
$3.48B
| – | – | -168,000 | Closed | -$3.7M |
|
25
Deutsche Bank
DB
$67.7B
| – | – | 0 | – | – |
|